Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Measuring US Pharmaceutical Industry R&D SpendingGolec, Joseph ; Vernon, JohnPharmacoEconomics, 2008-01, Vol.26 (12), p.1005-1017 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meetingEcarnot, Fiona ; Crepaldi, Gaetano ; Juvin, Philippe ; Grabenstein, John ; Del Giudice, Giuseppe ; Tan, Litjen ; O'Dwyer, Susan ; Esposito, Susanna ; Bosch, Xavier ; Gavazzi, Gaetan ; Papastergiou, John ; Gaillat, Jacques ; Johnson, Robert ; Fonzo, Marco ; Rossanese, Andrea ; Suitner, Caterina ; Barratt, Jane ; di Pasquale, Alberta ; Maggi, Stefania ; Michel, Jean-PierreBMC public health, 2019-12, Vol.19 (1), p.1698-1698, Article 1698 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Innovation in the pharmaceutical industry: New estimates of R&D costsDiMasi, Joseph A. ; Grabowski, Henry G. ; Hansen, Ronald W.Journal of health economics, 2016-05, Vol.47, p.20-33 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
US pharmaceutical companies sue to halt cuts in drug pricesJaffe, SusanThe Lancet (British edition), 2023-07, Vol.402 (10399), p.359-360 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testingTörnqvist, Elin ; Annas, Anita ; Granath, Britta ; Jalkesten, Elisabeth ; Cotgreave, Ian ; Öberg, Mattias Eller, KathrinPloS one, 2014-07, Vol.9 (7), p.e101638 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Misleading Congress About Drug Development: ReplyDiMasi, Joseph A. ; Hansen, Ronald W. ; Grabowski, Henry G.Journal of health politics, policy and law, 2008-04, Vol.33 (2), p.319-324 [Periódico revisado por pares]United States: Duke University PressTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
The evolving role of investigative toxicology in the pharmaceutical industryPognan, Francois ; Beilmann, Mario ; Boonen, Harrie C M ; Czich, Andreas ; Dear, Gordon ; Hewitt, Philip ; Mow, Tomas ; Oinonen, Teija ; Roth, Adrian ; Steger-Hartmann, Thomas ; Valentin, Jean-Pierre ; Van Goethem, Freddy ; Weaver, Richard J ; Newham, PeterNature reviews. Drug discovery, 2023-04, Vol.22 (4), p.317-335 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and AssessmentSchlander, Michael ; Hernandez-Villafuerte, Karla ; Cheng, Chih-Yuan ; Mestre-Ferrandiz, Jorge ; Baumann, MichaelPharmacoEconomics, 2021-11, Vol.39 (11), p.1243-1269 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
The problems with today's pharmaceutical business-an outsider's viewKessel, MarkNature biotechnology, 2011-01, Vol.29 (1), p.27-33 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light OnSismondo, SergioThe Journal of law, medicine & ethics, 2013-09, Vol.41 (3), p.635-643 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |